Radiofrequency ablation of metastatic lesions in adrenocortical cancer [3]

Annals of Internal Medicine

Volumn 133, Issue 4, 2000, Pages 312-313

  Abraham, J ^a   Fojo, T ^a   Wood, B J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; ETOPOSIDE; PACLITAXEL;

ADRENAL CORTEX CARCINOMA; ADRENALECTOMY; ADULT; CASE REPORT; CATHETER ABLATION; FEMALE; HUMAN; LETTER; MALE; METASTASIS; PRIORITY JOURNAL; RADIOFREQUENCY; TREATMENT OUTCOME;

EID: 0034662910     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-133-4-200008150-00028     Document Type: Letter

References (5)

1. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy
2. An eleven-year experience with adrenocortical carcinoma
3. Recurrent or metastatic disease in select patients with adrenocortical carcinoma. Aggressive resection vs chemotherapy
4. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: Treatment and follow-up in 16 patients
5. Large-volume tissue ablation with radio frequency by using a clustered, internally cooled electrode technique: Laboratory and clinical experience in liver metastases